Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Magda Verga"'
Autor:
Ornella Mastrogiacomo, Mario Lanfredini, Daniele Fagnani, Massimo Milani, G. Arpaia, Monica Carpenedo, Claudio Cimminiello, Magda Verga
Publikováno v:
Blood Coagulation & Fibrinolysis. 20:170-175
To see whether D-Dimer levels can identifying patients at high risk of venous thrombotic events and establish the best benefit/risk-of-bleeding ratio. Current guidelines do not recommend routine prophylaxis against venous thromboembolism (VTE) in can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a30273be632a59a3f559944dcf076c
https://doi.org/10.1097/mbc.0b013e32831bc2de
https://doi.org/10.1097/mbc.0b013e32831bc2de
Autor:
Elisabetta Terruzzi, Enrico Pogliani, Elena Maria Elli, Fausto Rossini, Matteo Parma, F. Morini, I. Miccolis, Monica Fumagalli, Luisa Verga, S. Cammarota, Magda Verga
This study was performed to evaluate the incidence, risk factors, and outcome of cytomegalovirus (CMV) infection in autologous stem cell transplantation (ASCT), with the aim of performing preemptive therapy in patients with antigenemia. Starting from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a09ede22fba42f2cf9e6f3c7ea9462
http://hdl.handle.net/10281/15070
http://hdl.handle.net/10281/15070
Autor:
Carlo, Gambacorti-Passerini, Massimo, Zucchetti, Domenico, Russo, Roberta, Frapolli, Magda, Verga, Silvia, Bungaro, Lucia, Tornaghi, Fabio, Rossi, Pietro, Pioltelli, Enrico, Pogliani, Daniele, Alberti, Gianmarco, Corneo, Maurizio, D'Incalci
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(2)
Imatinib (Glivec) is a potent inhibitor of bcr/abl, an oncogenic fusion protein that causes chronic myelogenous leukemia (CML). alpha1 acid glycoprotein (AGP) binds to imatinib with high affinity and inhibits imatinib activity in vitro and in vivo in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b966e0f9a05b4c00f39279478bff9cc8
https://pubmed.ncbi.nlm.nih.gov/12576428
https://pubmed.ncbi.nlm.nih.gov/12576428
Autor:
Carlo Gambacorti-Passerini, Holger Ruchatz, Silvia Bungaro, Roberta Frapolli, Gianmarco Corneo, Magda Verga, Pietro Pioltelli, Lucia Tornaghi, Francesca Rossi, Massimo Zucchetti, Leonardo Scapozza, Maurizio D'Incalci, Fabio Rossi, Enrico Maria Pogliani, Rosalind H. Gunby
Publikováno v:
Blood cells, moleculesdiseases. 28(3)
Imatinib mesylate (imatinib) inhibits Bcr/Abl, an oncogenic fusion protein. The in vitro effects of imatinib on BCR/ABL+ leukemic cells include inhibition of Bcr/Abl tyrosine phosphorylation, block of proliferation, and induction of apoptosis. The in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb6f3342dc924b054bea8f1ba1feebd
https://pubmed.ncbi.nlm.nih.gov/12367580
https://pubmed.ncbi.nlm.nih.gov/12367580
Autor:
Gian Marco Corneo, Enrico Pogliani, Edoardo Marchesi, Carlo Gambacorti-Passerini, Pietro Pioltelli, Magda Verga, Rossella Barni, Fabio Rossi, Francesca Rossi
Publikováno v:
British journal of haematology. 112(4)
STI571 (CGP57148B) is an inhibitor of BCR/ABL, the cause of chronic myeloid leukaemia (CML). A difference exists between CML patients in chronic phase, in which responses to STI571are durable, and patients in blast crisis, who generally experience on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c82d6f8d59c98621a3b290b8ab5e1f26
https://pubmed.ncbi.nlm.nih.gov/11298594
https://pubmed.ncbi.nlm.nih.gov/11298594
Autor:
Gambacorti-Passerini, Carlo, Barni, Rossella, Marchesi, Edoardo, Verga, Magda, Rossi, Francesca, Rossi, Fabio, Pioltelli, Pietro, Pogliani, Enrico, Corneo, Gian Marco
Publikováno v:
British Journal of Haematology; Mar2001, Vol. 112 Issue 4, p972, 3p, 1 Chart, 1 Graph